Literature DB >> 28514511

Experiences of xerostomia after radiotherapy in patients with head and neck cancer: A qualitative study.

Nan Jiang1,2, Yue Zhao2, Henrik Jansson1,3, Xiaocen Chen4, Jan Mårtensson1.   

Abstract

AIMS AND
OBJECTIVES: To describe the experiences of radiation-induced xerostomia in patients with head and neck cancer.
BACKGROUND: Xerostomia is the most commonly occurring complication during and following radiotherapy. It can persist for several months or years and can have a significant impact on patients' quality of life.
DESIGN: This was a qualitative descriptive study.
METHODS: Semi-structured interviews were conducted with a sample of 20 participants. Inductive content analysis was used to analyse the qualitative data.
RESULTS: Analysis of the manifest content identified five categories: communication problems, physical problems, psychosocial problems, treatment problems and relief strategies. The latent content was formulated into a theme: due to lack of information from professionals, the patients had to find their own solutions for their problems.
CONCLUSIONS: Xerostomia is not only a biophysical symptom but also has a profound effect on the emotional, intellectual and sociocultural dimensions of life. The majority of patients continued to suffer from xerostomia and its associated symptoms after radiotherapy, in part, because of a lack of professional support, including the inability of nurses to provide oral health care. RELEVANCE TO CLINICAL PRACTICE: Nurses need to be knowledgeable about the effects of radiotherapy on oral mucosa and about appropriate interventions. The healthcare system requires a symptom management platform for radiation-induced complications, to help patients, their families and healthcare professionals obtain information about self-care, treatments and relief strategies.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  cancer; content analysis; oncology nursing; oral care; qualitative study

Mesh:

Year:  2017        PMID: 28514511     DOI: 10.1111/jocn.13879

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  6 in total

1.  The effects of the orthopedic metal artifact reduction (O-MAR) algorithm on contouring and dosimetry of head and neck radiotherapy patients.

Authors:  Jussi Sillanpaa; Michael Lovelock; Boris Mueller
Journal:  Med Dosim       Date:  2019-07-30       Impact factor: 1.482

2.  Early Changes in Serial CBCT-Measured Parotid Gland Biomarkers Predict Chronic Xerostomia After Head and Neck Radiation Therapy.

Authors:  Benjamin S Rosen; Peter G Hawkins; Daniel F Polan; James M Balter; Kristy K Brock; Justin D Kamp; Christina M Lockhart; Avraham Eisbruch; Michelle L Mierzwa; Randall K Ten Haken; Issam El Naqa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-07-10       Impact factor: 7.038

3.  Predicting late radiation-induced xerostomia with parotid gland PET biomarkers and dose metrics.

Authors:  Joel R Wilkie; Michelle L Mierzwa; Keith A Casper; Charles S Mayo; Matthew J Schipper; Avraham Eisbruch; Francis P Worden; Issam El Naqa; Benjamin L Viglianti; Benjamin S Rosen
Journal:  Radiother Oncol       Date:  2020-04-06       Impact factor: 6.280

Review 4.  A qualitative systematic review of the social eating and drinking experiences of patients following treatment for head and neck cancer.

Authors:  Mark Dornan; Cherith Semple; Anne Moorhead; Eilís McCaughan
Journal:  Support Care Cancer       Date:  2021-03-01       Impact factor: 3.603

5.  Research Value of Intensity Modulated Radiation Therapy in Alleviating Parotid Gland Function Injury in Patients with Stage N0 Nasopharyngeal Carcinoma from Physical and Dosimetric Aspects.

Authors:  Lirong Zheng; Hong Wang; Neng Yang; Fenglei Du; Lin Xiao; Gangfeng Wu
Journal:  Comput Math Methods Med       Date:  2022-07-11       Impact factor: 2.809

Review 6.  The Multidisciplinary Team (MDT) Approach and Quality of Care.

Authors:  Miren Taberna; Francisco Gil Moncayo; Enric Jané-Salas; Maite Antonio; Lorena Arribas; Esther Vilajosana; Elisabet Peralvez Torres; Ricard Mesía
Journal:  Front Oncol       Date:  2020-03-20       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.